Evidence map›Paper›PMID 28373876›Full record

ArticleFrontiers in immunology2017

IL-21 Receptor Antagonist Inhibits Differentiation of B Cells toward Plasmablasts upon Alloantigen Stimulation.

Kitty de Leur, Frank J M F Dor, Marjolein Dieterich, Luc J W van der Laan, Rudi W Hendriks, Carla C Baan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Therapies for Chronic Allograft Rejection.Frontiers in pharmacology · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kitty de LeurDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands; Division of HPB and Transplant Surgery, Department of Surgery, Erasmus MC, University Medical Center, Rotterdam, Netherlands.
Frank J M F DorDivision of HPB and Transplant Surgery, Department of Surgery, Erasmus MC, University Medical Center , Rotterdam , Netherlands.
Marjolein DieterichDepartment of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam , Netherlands.
Luc J W van der LaanDivision of HPB and Transplant Surgery, Department of Surgery, Erasmus MC, University Medical Center , Rotterdam , Netherlands.
Rudi W HendriksDepartment of Pulmonary Medicine, Erasmus MC, University Medical Center , Rotterdam , Netherlands.
Carla C BaanDepartment of Internal Medicine, Erasmus MC, University Medical Center , Rotterdam , Netherlands.
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interaction between T follicular helper (Tfh) cells and B cells is complex and involves various pathways, including the production of IL-21 by the Tfh cells. Secretion of IL-21 results in B cell differentiation toward immunoglobulin-producing plasmablasts. In patients after kidney transplantation, the formation of alloantibodies produced by donor antigen-activated B cells are a major cause of organ failure. In this allogeneic response, the role of IL-21-producing Tfh cells that regulate B cell differentiation is unknown. Here, we tested, in an alloantigen-driven setting, whether Tfh cell help signals control B cell differentiation with its dependency on IL-21. Pre-transplantation patient PBMCs were sorted into pure CD4

Indexed as

alloreactivityB cell differentiationfollicular T-helper cellIL-21 receptorplasmablast

Identifiers

PMID28373876
PMCPMC5357809
OpenAlexW2600476949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.